相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma
Carmen Behrens et al.
CLINICAL LUNG CANCER (2021)
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors
Jhajaira M. Araujo et al.
FRONTIERS IN ONCOLOGY (2021)
Why leveraging sex differences in immune trade-offs may illuminate the evolution of senescence
Charlotte Jessica E. Metcalf et al.
FUNCTIONAL ECOLOGY (2020)
Sex-associated molecular differences for cancer immunotherapy
Youqiong Ye et al.
NATURE COMMUNICATIONS (2020)
Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset
Neil Mundi et al.
ORAL ONCOLOGY (2020)
Sex differences in oncogenic mutational processes
Constance H. Li et al.
NATURE COMMUNICATIONS (2020)
Strength of immune selection in tumors varies with sex and age
Andrea Castro et al.
NATURE COMMUNICATIONS (2020)
Considering how biological sex impacts immune responses and COVID-19 outcomes
Eileen P. Scully et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment
F. Conforti et al.
ANNALS OF ONCOLOGY (2019)
Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays
David B. Chapel et al.
HUMAN PATHOLOGY (2019)
Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
Lianzhou Yang et al.
ONCOTARGETS AND THERAPY (2019)
Distinct molecular etiologies of male and female hepatocellular carcinoma
Heini M. Natri et al.
BMC CANCER (2019)
Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer
Orgilmaa Regzedmaa et al.
ONCOTARGETS AND THERAPY (2019)
Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network
Sue Haupt et al.
NATURE COMMUNICATIONS (2019)
Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features
Baoan Hong et al.
CLINICAL GENITOURINARY CANCER (2019)
PD-L1 expression and association Chock for with malignant behavior in updates pheochromocytomas/paragangliomas
Dan Guo et al.
HUMAN PATHOLOGY (2019)
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
Wei Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers A Systematic Review and Meta-analysis
Christopher J. D. Wallis et al.
JAMA ONCOLOGY (2019)
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti et al.
LANCET ONCOLOGY (2018)
No evidence for the immunocompetence handicap hypothesis in male humans
Judyta Nowak et al.
SCIENTIFIC REPORTS (2018)
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
Hui-Shan Huang et al.
SCIENTIFIC REPORTS (2018)
Sexual dimorphism in bacterial infections
Edgar Ricardo Vazquez-Martinez et al.
BIOLOGY OF SEX DIFFERENCES (2018)
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma
Ching Ying Lin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sex Differences in Cancer Driver Genes and Biomarkers
Constance H. Li et al.
CANCER RESEARCH (2018)
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Mauricio S. Caetano et al.
NATURE COMMUNICATIONS (2018)
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
Joseph A. Pinto et al.
ESMO OPEN (2018)
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody et al.
LUNG CANCER (2017)
Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer
Oscar Siu Hong Chan et al.
ORAL ONCOLOGY (2017)
Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy
Chao Liu et al.
ONCOTARGET (2017)
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC
Haitao Yang et al.
ONCOTARGET (2017)
The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
Shafei Wu et al.
ONCOTARGET (2017)
Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
Yunjian Pan et al.
JOURNAL OF THORACIC DISEASE (2017)
Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer
Aranzazu Lafuente-Sanchis et al.
CLINICAL LUNG CANCER (2017)
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
Jhajaira M. Araujo et al.
ONCOTARGET (2016)
Systematic Analysis of Sex-Linked Molecular Alterations and Therapies in Cancer
Jonathan Ma et al.
SCIENTIFIC REPORTS (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Individuality and Variation of Personal Regulomes in Primary Human T Cells
Kun Qu et al.
CELL SYSTEMS (2015)
Lymphocyte Subsets: Reference Ranges in an Age- and Gender-Balanced Population of Omani Healthy Adults
Adhra Al-Mawali et al.
CYTOMETRY PART A (2013)
Influence of Age, Gender and Lifestyle in Lymphocyte Subsets: Report from the Spanish Gait-2 Study
Maria Concepcion Garcia-Dabrio et al.
ACTA HAEMATOLOGICA (2012)
Sex Disparities in Cancer Mortality and Survival
Michael B. Cook et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Genetic and molecular insights into the development and evolution of sexual dimorphism
Thomas M. Williams et al.
NATURE REVIEWS GENETICS (2009)
On sexual dimorphism in immune function
Charles L. Nunn et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
The X-files in immunity: sex-based differences predispose immune responses
Eleanor N. Fish
NATURE REVIEWS IMMUNOLOGY (2008)
Sexually dimorphic gene expression in mammalian somatic tissue
Joerg Isensee et al.
GENDER MEDICINE (2007)
Sexual dimorphism in innate immune responses to infectious organisms
Ian Marriott et al.
IMMUNOLOGIC RESEARCH (2006)
Reference ranges of lymphocyte subsets of healthy adults in Turkey
A Yaman et al.
MEDICAL PRINCIPLES AND PRACTICE (2005)
Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland
LR Bisset et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Primate mating systems and the evolution of immune response
MJ Anderson et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
Reference values of lymphocyte subsets in the normal healthy adult Kuwaiti Arab population
SA Kaaba et al.
IMMUNOLOGY LETTERS (2002)
分享论文
